» Articles » PMID: 9675783

The Biology and Clinical Applications of Dendritic Cells

Overview
Journal Transfus Med
Specialty Hematology
Date 1998 Jul 24
PMID 9675783
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Dendritic cells (DC) have an essential role in the induction of immune responses to antigen by naive T cells. As 'professional' antigen-presenting cells they are specialized to take up, process and present soluble antigens in complexes with either class I or class II MHC molecules. They are present in only trace numbers in most tissues and in a relatively immature state but, in the presence of inflammatory signals, they rapidly take up foreign antigens and undergo maturation into potent antigen-presenting cells that migrate to secondary lymphoid tissue where they initiate an immune response. It is now possible to expand populations of DC in vitro both from primitive haemopoietic progenitors as well as from more mature peripheral blood mononuclear cells. This has shed light on many developmental aspects of DC biology and furthered our knowledge of the mechanisms of antigen processing and presentation. It is clear that there is more than one pathway of DC differentiation and that some DC may actually induce immunological unresponsiveness--a possible mechanism for tolerance to self-antigens. For clinicians the most exciting prospect is of their use as cellular adjuvants to generate beneficial responses to antigens of low immunogenicity such as tumour antigens. This review outlines aspects of human DC development and the way in which a greater understanding of their biology may lead to promising clinical applications.

Citing Articles

Pathophysiological Roles of Histamine Receptors in Cancer Progression: Implications and Perspectives as Potential Molecular Targets.

Nguyen P, Cho J Biomolecules. 2021; 11(8).

PMID: 34439898 PMC: 8392479. DOI: 10.3390/biom11081232.


Mechanisms of immune suppression by interleukin-10 and transforming growth factor-beta: the role of T regulatory cells.

Taylor A, Verhagen J, Blaser K, Akdis M, Akdis C Immunology. 2006; 117(4):433-42.

PMID: 16556256 PMC: 1782242. DOI: 10.1111/j.1365-2567.2006.02321.x.


Generation in vitro of B-cell chronic lymphocytic leukaemia-proliferative and specific HLA class-II-restricted cytotoxic T-cell responses using autologous dendritic cells pulsed with tumour cell lysate.

Goddard R, Prentice A, Copplestone J, Kaminski E Clin Exp Immunol. 2001; 126(1):16-28.

PMID: 11678895 PMC: 1906182. DOI: 10.1046/j.1365-2249.2001.01617.x.


Construction of a single-chain interleukin-12-expressing retroviral vector and its application in cytokine gene therapy against experimental coccidioidomycosis.

Jiang C, Magee D, Cox R Infect Immun. 1999; 67(6):2996-3001.

PMID: 10338510 PMC: 96611. DOI: 10.1128/IAI.67.6.2996-3001.1999.